MCP-1 expression in CNS-1 astrocytoma cells: Implications for macrophage infiltration into tumors in vivo

T. Kielian, N. Van Rooijen, W. F. Hickey

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Gliomas are among the most resistant tumors to conventional anti-tumor therapy, and are typified by their highly infiltrative nature and ill-defined borders. Macrophages constitute a major proportion of the tumor cell mass in both primary human gliomas and as shown here, a CNS-1 glioma model. The objective of this study was to identify tumor-cell-derived chemotactic factor(s) which participate in macrophage recruitment into tumors in vivo. This study demonstrates the constitutive expression of monocyte chemoattractant protein-1 (MCP-1), a potent monocyte chemoattractant, by the rat astrocytoma cell line CNS-1. Characterization of cytokine expression by CNS-1 cells in vitro revealed the constitutive expression of TGF-β but not other proinflammatory cytokines. However, numerous cytokines were detected in CNS-1 tumors in vivo including Ltβ, IL-1α, IL-1β, TNF-α, TNF-β, IL-10, and IFN-γ. Attenuation of MCP-1 release from CNS-1 cells using an anti-sense approach revealed no significant alterations in macrophage infiltration into tumors in vivo, suggesting redundancy in the signal(s) involved in macrophage recruitment. Depletion of peripheral macrophages using liposome-encapsulated clodronate revealed no significant differences in tumor growth or in the degree of macrophage infiltration into CNS-1 tumors in vivo. These results indicate that CNS-1 cells produce chemotactic factors which likely participate in macrophage recruitment into tumors in vivo. Whether or not macrophage recruitment confers a growth advantage for the tumor remains to be determined.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalJournal of Neuro-Oncology
Volume56
Issue number1
DOIs
StatePublished - Apr 9 2002

Fingerprint

Chemokine CCL2
Astrocytoma
Macrophages
Neoplasms
Chemotactic Factors
Glioma
Cytokines
Interleukin-1
Clodronic Acid
Growth
Liposomes
Interleukin-10
Monocytes
Cell Line

Keywords

  • Astrocytoma
  • MCP-1
  • Macrophages
  • TGF-β

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

MCP-1 expression in CNS-1 astrocytoma cells : Implications for macrophage infiltration into tumors in vivo. / Kielian, T.; Van Rooijen, N.; Hickey, W. F.

In: Journal of Neuro-Oncology, Vol. 56, No. 1, 09.04.2002, p. 1-12.

Research output: Contribution to journalArticle

@article{3b85d18cf7824eb8bf1481712c4df0dd,
title = "MCP-1 expression in CNS-1 astrocytoma cells: Implications for macrophage infiltration into tumors in vivo",
abstract = "Gliomas are among the most resistant tumors to conventional anti-tumor therapy, and are typified by their highly infiltrative nature and ill-defined borders. Macrophages constitute a major proportion of the tumor cell mass in both primary human gliomas and as shown here, a CNS-1 glioma model. The objective of this study was to identify tumor-cell-derived chemotactic factor(s) which participate in macrophage recruitment into tumors in vivo. This study demonstrates the constitutive expression of monocyte chemoattractant protein-1 (MCP-1), a potent monocyte chemoattractant, by the rat astrocytoma cell line CNS-1. Characterization of cytokine expression by CNS-1 cells in vitro revealed the constitutive expression of TGF-β but not other proinflammatory cytokines. However, numerous cytokines were detected in CNS-1 tumors in vivo including Ltβ, IL-1α, IL-1β, TNF-α, TNF-β, IL-10, and IFN-γ. Attenuation of MCP-1 release from CNS-1 cells using an anti-sense approach revealed no significant alterations in macrophage infiltration into tumors in vivo, suggesting redundancy in the signal(s) involved in macrophage recruitment. Depletion of peripheral macrophages using liposome-encapsulated clodronate revealed no significant differences in tumor growth or in the degree of macrophage infiltration into CNS-1 tumors in vivo. These results indicate that CNS-1 cells produce chemotactic factors which likely participate in macrophage recruitment into tumors in vivo. Whether or not macrophage recruitment confers a growth advantage for the tumor remains to be determined.",
keywords = "Astrocytoma, MCP-1, Macrophages, TGF-β",
author = "T. Kielian and {Van Rooijen}, N. and Hickey, {W. F.}",
year = "2002",
month = "4",
day = "9",
doi = "10.1023/A:1014495613455",
language = "English (US)",
volume = "56",
pages = "1--12",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - MCP-1 expression in CNS-1 astrocytoma cells

T2 - Implications for macrophage infiltration into tumors in vivo

AU - Kielian, T.

AU - Van Rooijen, N.

AU - Hickey, W. F.

PY - 2002/4/9

Y1 - 2002/4/9

N2 - Gliomas are among the most resistant tumors to conventional anti-tumor therapy, and are typified by their highly infiltrative nature and ill-defined borders. Macrophages constitute a major proportion of the tumor cell mass in both primary human gliomas and as shown here, a CNS-1 glioma model. The objective of this study was to identify tumor-cell-derived chemotactic factor(s) which participate in macrophage recruitment into tumors in vivo. This study demonstrates the constitutive expression of monocyte chemoattractant protein-1 (MCP-1), a potent monocyte chemoattractant, by the rat astrocytoma cell line CNS-1. Characterization of cytokine expression by CNS-1 cells in vitro revealed the constitutive expression of TGF-β but not other proinflammatory cytokines. However, numerous cytokines were detected in CNS-1 tumors in vivo including Ltβ, IL-1α, IL-1β, TNF-α, TNF-β, IL-10, and IFN-γ. Attenuation of MCP-1 release from CNS-1 cells using an anti-sense approach revealed no significant alterations in macrophage infiltration into tumors in vivo, suggesting redundancy in the signal(s) involved in macrophage recruitment. Depletion of peripheral macrophages using liposome-encapsulated clodronate revealed no significant differences in tumor growth or in the degree of macrophage infiltration into CNS-1 tumors in vivo. These results indicate that CNS-1 cells produce chemotactic factors which likely participate in macrophage recruitment into tumors in vivo. Whether or not macrophage recruitment confers a growth advantage for the tumor remains to be determined.

AB - Gliomas are among the most resistant tumors to conventional anti-tumor therapy, and are typified by their highly infiltrative nature and ill-defined borders. Macrophages constitute a major proportion of the tumor cell mass in both primary human gliomas and as shown here, a CNS-1 glioma model. The objective of this study was to identify tumor-cell-derived chemotactic factor(s) which participate in macrophage recruitment into tumors in vivo. This study demonstrates the constitutive expression of monocyte chemoattractant protein-1 (MCP-1), a potent monocyte chemoattractant, by the rat astrocytoma cell line CNS-1. Characterization of cytokine expression by CNS-1 cells in vitro revealed the constitutive expression of TGF-β but not other proinflammatory cytokines. However, numerous cytokines were detected in CNS-1 tumors in vivo including Ltβ, IL-1α, IL-1β, TNF-α, TNF-β, IL-10, and IFN-γ. Attenuation of MCP-1 release from CNS-1 cells using an anti-sense approach revealed no significant alterations in macrophage infiltration into tumors in vivo, suggesting redundancy in the signal(s) involved in macrophage recruitment. Depletion of peripheral macrophages using liposome-encapsulated clodronate revealed no significant differences in tumor growth or in the degree of macrophage infiltration into CNS-1 tumors in vivo. These results indicate that CNS-1 cells produce chemotactic factors which likely participate in macrophage recruitment into tumors in vivo. Whether or not macrophage recruitment confers a growth advantage for the tumor remains to be determined.

KW - Astrocytoma

KW - MCP-1

KW - Macrophages

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=0036206606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036206606&partnerID=8YFLogxK

U2 - 10.1023/A:1014495613455

DO - 10.1023/A:1014495613455

M3 - Article

C2 - 11949821

AN - SCOPUS:0036206606

VL - 56

SP - 1

EP - 12

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -